Characterization of a nontoxic monophosphoryl lipid A.

Arthur G Johnson, M. Tomai, L. Solem, L. Beck, E. Ribi

Research output: Contribution to journalReview articlepeer-review

48 Scopus citations


Gram-negative bacterial endotoxins constitute some of the strongest immunologic adjuvants known. Precluding their use as adjuvants in humans has been the exquisite toxicity of these compounds in extraordinarily small amounts. With the acquisition of precise knowledge of the structure of the active moiety, detoxifying procedures have been developed. These have resulted in the isolation of a monophosphoryl lipid A with a much reduced toxicity that retains the capacity to act as an adjuvant in young mice as well as in immunodeficient aging mice.

Original languageEnglish (US)
Pages (from-to)S512-516
JournalReviews of infectious diseases
Volume9 Suppl 5
StatePublished - Jan 1 1987


Dive into the research topics of 'Characterization of a nontoxic monophosphoryl lipid A.'. Together they form a unique fingerprint.

Cite this